cyclohexanol has been researched along with isoxazoles in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albano, D; Amchin, J; Klockowski, PM; Taylor, KP; Zarycranski, W | 1 |
| Carroll, FI; Howard, JL; Navarro, HA; Pollard, GT | 1 |
| Becker, A; Höllt, V; Schröder, H | 1 |
| Abernethy, L; Ansari, N; Cameron, K; Clarkson, T; Dempster, M; Dunn, D; Easson, AM; Edwards, D; Everett, K; Feilden, H; Ho, KK; Kultgen, S; Littlewood, P; Maclean, J; McArthur, D; McGregor, D; McLuskey, H; Neagu, I; Neale, S; Nisbet, LA; Ohlmeyer, M; Palin, R; Pham, Q; Ratcliffe, P; Rong, Y; Roughton, A; Sammons, M; Swanson, R; Tracey, H; Walker, G | 1 |
| Liang, CS; Yang, FW | 1 |
| Abernethy, L; Ansari, N; Cameron, K; Clarkson, T; Dempster, M; Dunn, D; Easson, AM; Edwards, D; Everett, K; Feilden, H; Ho, KK; Kultgen, S; Littlewood, P; Maclean, J; McArthur, D; McGregor, D; McLuskey, H; Neagu, I; Nimz, O; Nisbet, LA; Ohlmeyer, M; Palin, R; Pham, Q; Ratcliffe, P; Rong, Y; Roughton, A; Sammons, M; Swanson, R; Tracey, H; Walker, G | 1 |
| Bearman, P; Essick, C; King, M; Ross, JS | 1 |
7 other study(ies) available for cyclohexanol and isoxazoles
| Article | Year |
|---|---|
Effect of venlafaxine on the pharmacokinetics of risperidone.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Area Under Curve; Cyclohexanols; Desvenlafaxine Succinate; Exploratory Behavior; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Paliperidone Palmitate; Psychomotor Performance; Pyrimidines; Risperidone; Venlafaxine Hydrochloride | 1999 |
Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter.
Topics: Allosteric Regulation; Animals; Calcium; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Dopamine Plasma Membrane Transport Proteins; Humans; Isoxazoles; Male; Mice; Motor Activity; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Tropanes | 2009 |
Parecoxib and its metabolite valdecoxib directly interact with cannabinoid binding sites in CB1-expressing HEK 293 cells and rat brain tissue.
Topics: Amino Acids; Animals; Binding, Competitive; Brain Chemistry; Cyclic AMP; Cyclohexanols; Cyclooxygenase 2 Inhibitors; gamma-Aminobutyric Acid; Glutamic Acid; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Isoxazoles; Male; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Sulfonamides; Transfection | 2011 |
Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists.
Topics: Amides; Animals; Antihypertensive Agents; Cyclohexanols; Hyperthermia, Induced; Isoxazoles; Rats; Rats, Wistar; Structure-Activity Relationship; TRPV Cation Channels | 2011 |
Paliperidone augmentation for treatment-resistant depression: a case report.
Topics: Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Pyrimidines; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles.
Topics: Administration, Oral; Amides; Animals; Capsaicin; Cyclohexanols; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Isoxazoles; Microsomes, Liver; Rats; Structure-Activity Relationship; TRPV Cation Channels | 2011 |
Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Case-Control Studies; Central Nervous System Stimulants; Cyclohexanols; Desvenlafaxine Succinate; Dextroamphetamine; Drug Industry; Gift Giving; Health Care Sector; Humans; Interprofessional Relations; Isoxazoles; Marketing of Health Services; Organizational Policy; Paliperidone Palmitate; Practice Patterns, Physicians'; Psychotropic Drugs; Pyrimidines; Schools, Medical; United States | 2013 |